Loading data
GRNDNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 439.9 m USD | 344.64 m USD | 259.69 m USD | 195.02 m USD | 145.83 m USD |
| Research and development expense | 48.93 m USD | 32.81 m USD | 29.33 m USD | 17.9 m USD | 10.91 m USD |
| Selling, general and administrative expense | 143.26 m USD | 114.74 m USD | 80.42 m USD | 75.3 m USD | 30.62 m USD |
| Operating profit | 126.29 m USD | 92.6 m USD | 55.45 m USD | 13.04 m USD | 23.71 m USD |
| Profit before tax | 118.61 m USD | -118.29 m USD | -51.75 m USD | -7 k USD | 6.3 m USD |
| Income tax expense | 23.86 m USD | 12.71 m USD | 4.02 m USD | -859 k USD | 1.24 m USD |
| Net income (reported basis) | 94.75 m USD | -131 m USD | -55.77 m USD | 852 k USD | 5.06 m USD |
| Basic earnings per share | 0.45 USD/share | -0.74 USD/share | -0.32 USD/share | 0.01 USD/share | 0.03 USD/share |
| Diluted earnings per share | 0.43 USD/share | -0.74 USD/share | -0.32 USD/share | 0.01 USD/share | 0.03 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.